Trades on 2 secondary markets

Formation Bio

Formation Bio (formerly TrialSpark, founded 2016 in New York City) is a tech-driven, AI-native pharmaceutical company that aims to bring new treatments to patients faster and more efficiently. Rather than discovering drugs, Formation Bio in-licenses and acquires clinical-stage drug assets from pharm

minimal 11.7 / 100 0 APIs View provider profile →

Company Pharmaceutical Biotechnology Drug Development Clinical Trials Artificial Intelligence

Formation Bio is an API provider whose private shares are listed on 2 secondary markets: Hiive, Nasdaq Private Market.

Where It Trades

H Hiive View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.